OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

AstraZeneca PLC/  GB0009895292  /

Cboe Europe BXE
30/04/2024  10:01:15 Chg. - Volume Bid14:26:23 Ask15:26:06 Market Capitalization Dividend Y. P/E Ratio
1,660.75SEK - 35
Turnover: 58,126.25		 -Bid Size: - -Ask Size: - 2522.55 bill.SEK - -
GlobeNewswire 29/04 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 25/04 Europe opens mostly down after corporate earnings
TeleTrader 25/04 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 01/04 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire 28/03 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire 19/03 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
TeleTrader 19/03 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 18/03 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 14/03 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 14/03 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 28/02 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
GlobeNewswire 26/02 FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 26/02 FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire 22/02 Gracell Biotechnologies Acquisition Completed
GlobeNewswire 22/02 Sodexo and AstraZeneca extend their global partnership for a further 5 years.
GlobeNewswire 20/02 Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
TeleTrader 19/02 Europe closes mostly flat with eyes on earnings, data
TeleTrader 12/02 US opens mostly lower with CPI in focus
TeleTrader 08/02 Europe closes mostly higher following earnings
TeleTrader 08/02 AstraZeneca sinks almost 7% after missing operating profit estimates
TeleTrader 08/02 AstraZeneca's revenue in Q4 rises 5% to $11.3B
GlobeNewswire 05/02 Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire 02/02 BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...
GlobeNewswire 16/01 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Bioph...
GlobeNewswire 10/01 Absci Appoints Professor Sir Mene Pangalos to its Board of Directors